METTL3 and adenomyosis: Zhai et al. confirmed that the METTL3-mediated m6A modification was capable of targeting and regulating the expression of critical genes, including insulin-like growth factor 1 (IGF1) and the detoxifying enzyme DDT, that influenced the invasiveness of adenomyosis.